The Cholesterol Myths: Exposing the Fallacy That Saturated Fat and Cholesterol Cause Heart Disease: Summary & Key Insights

When the cholesterol hypothesis took hold in the mid‑20th century, it seemed elegant and convincing: dietary fat raises blood cholesterol, high cholesterol clogs arteries, and clogged arteries cause heart attacks. The simplicity of this chain made it appealing to both scientists and the public. Yet from the beginning, the data were ambiguous. In examining the early history of this idea, I found that it grew less out of solid evidence and more out of correlation—a pattern noticed, then embraced, long before it was properly tested.

Ancel Keys’s famous Seven Countries Study is often credited with launching the cholesterol era. Keys compared rates of heart disease in different countries and noticed a rough correlation with fat consumption. But such studies were ecological and selective; they could not account for all the variables that distinguish one population from another, such as lifestyle, genetics, or even differences in how heart disease is diagnosed. In fact, many countries that did not fit the pattern—nations where people ate plenty of fat but had low incidence of heart disease—were omitted from the analysis. Despite this, the narrative was too appealing to let go: fat was the culprit, and cholesterol the marker. That story began to shape medical education, public policy, and virtually all nutritional advice.

Epidemiological studies have long been used to justify the cholesterol hypothesis, but as I stress in the book, correlation does not mean causation. Large population studies such as the Framingham Heart Study were initially interpreted as supporting the link between cholesterol levels and heart disease. Yet even there, closer inspection reveals contradictions. After decades of follow‑up, the differences in cholesterol levels among people who developed heart disease and those who did not were minimal. Interestingly, older participants with higher cholesterol often lived longer than those with lower levels.

These inconsistencies should have prompted a re‑examination of the central theory, but instead, they were rationalized. New surrogate explanations were introduced—“good” and “bad” cholesterol distinctions, shifting endpoints, and subgroup analyses—all meant to preserve the core belief that cholesterol control must remain central to prevention. Scientific reasoning became subordinate to the desire for coherence.